EsoCap completes patient recruitment in ACESO phase II trial in eosinophilic esophagitis
EsoCap's novel targeted delivery platform is designed to increase mucosal contact time and drug deposition in the esophagus ESO-101, EsoCap's lead product candidate, consists of a capsule with a rolled-up,…